SCHEMBL9979264

SCHEMBL9979264

Cl[Si](c1ccccc1)(c1ccccc1)[Si](Cl)(c1ccccc1)c1ccccc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 6/20 0.39
TDP1 Q9NUW8 4/20 0.36
ALDH1A1 P00352 3/20 0.36
HSD17B10 Q99714 1/20 0.36
ESR1 P03372 1/20 0.36
ESR2 Q92731 1/20 0.36
LMNA P02545 2/20 0.33
BBOX1 O75936 1/20 0.33
EHMT2 Q96KQ7 1/20 0.33
EHMT1 Q9H9B1 1/20 0.33
NPC1 O15118 1/20 0.33
MAPK1 P28482 1/20 0.33
RAB9A P51151 1/20 0.33
MAOA P21397 1/20 0.33
MAOB P27338 1/20 0.33
ORAI1 Q96D31 1/20 0.32
ORAI2 Q96SN7 1/20 0.32
ORAI3 Q9BRQ5 1/20 0.32
TRPV6 Q9H1D0 1/20 0.32
CYP1A2 P05177 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Benzene SCHEMBL28553774 0.79 TSHR (0.39) TSHRTDP1ALDH1A1HSD17B10ESR1
SCHEMBL197123 0.79 TSHR (0.39) TSHRTDP1ALDH1A1HSD17B10ESR1
SCHEMBL38744 0.79 TSHR (0.39) TSHRTDP1ALDH1A1HSD17B10ESR1
SCHEMBL76000 0.79 TSHR (0.39) TSHRTDP1ALDH1A1HSD17B10ESR1
SCHEMBL9763697 0.79 TSHR (0.39) TSHRTDP1ALDH1A1HSD17B10ESR1
SCHEMBL29120692 0.79 TSHR (0.39) TSHRTDP1ALDH1A1HSD17B10ESR1
SCHEMBL9291948 0.78 TSHR (0.33) TSHRTDP1ALDH1A1HSD17B10ESR1
Fluoride SCHEMBL5604818 0.76 TSHR (0.37) TSHRTDP1ALDH1A1HSD17B10ESR1
SCHEMBL704206 0.76 ESR1 (0.40) TSHRTDP1ALDH1A1HSD17B10ESR1
SCHEMBL705847 0.76 ESR1 (0.40) TSHRTDP1ALDH1A1HSD17B10ESR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11261202-B2 Catalytic reduction of halogenated carbosilanes and halogenated carbodisilanes L'Air Liquide, Société Anonyme pour l'Etude et l'Exploitation des Procédés Georges Claude (FR) 2022-03-01 US disclosed
EP-2580255-B1 POLYARYLACETYLENES CONTAINING SILOXANE, SILANE, AND CARBORANE MOIETIES US GOV SEC NAVY (US) 2016-09-07 EP disclosed
US-8440850-B2 Polyarylacetylenes containing siloxane, silane, and carborane moieties THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) 2013-05-14 US disclosed
EP-2580255-A2 POLYARYLACETYLENES CONTAINING SILOXANE, SILANE, AND CARBORANE MOIETIES The Government of the United States of America as represented by the Secretary of the Navy (US) 2013-04-17 EP disclosed
US-8269030-B2 Polyarylacetylenes containing siloxane, silane, and carborane moieties THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) 2012-09-18 US disclosed
US-20120190808-A1 POLYARYLACETYLENES CONTAINING SILOXANE, SILANE, AND CARBORANE MOIETIES THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) 2012-07-26 US disclosed
US-20120184699-A1 POLYARYLACETYLENES CONTAINING SILOXANE, SILANE, AND CARBORANE MOIETIES The Government of the United State of America, as represented by the Secretary of the Navy (US) 2012-07-19 US disclosed
US-8217194-B2 Polyarylacetylenes containing siloxane, silane, and carborane moieties THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) 2012-07-10 US disclosed
WO-2011156678-A2 POLYARYLACETYLENES CONTAINING SILOXANE, SILANE, AND CARBORANE MOIETIES THE GOVERNMENT OF THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) 2011-12-15 WO disclosed
US-20110306744-A1 POLYARYLACETYLENES CONTAINING SILOXANE, SILANE, AND CARBORANE MOIETIES THE GOVERNMENT OF THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) 2011-12-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110306744-A1 POLYARYLACETYLENES CONTAINING SILOXANE, SILANE, AND CARBORANE MOIETIES SIRT2, SUMO2, MCM2 TSHR 4621/4885TDP1 4376/4885ALDH1A1 3215/4885
US-20120190808-A1 POLYARYLACETYLENES CONTAINING SILOXANE, SILANE, AND CARBORANE MOIETIES SIRT2, SUMO2, MCM2 TSHR 4394/4885TDP1 4292/4885ALDH1A1 3588/4885
US-20120184699-A1 POLYARYLACETYLENES CONTAINING SILOXANE, SILANE, AND CARBORANE MOIETIES SIRT2, SUMO2, MCM2 TSHR 4632/4885TDP1 4375/4885ALDH1A1 3126/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.